domingo, 19 de diciembre de 2010

Cost-Effectiveness of Genetic Testing in Family Me... [Circ Cardiovasc Qual Outcomes. 2010] - PubMed result



Circ Cardiovasc Qual Outcomes. 2010 Dec 7. [Epub ahead of print]
Cost-Effectiveness of Genetic Testing in Family Members of Patients With Long-QT Syndrome.

Perez MV, Kumarasamy NA, Owens DK, Wang PJ, Hlatky MA.

Stanford University School of Medicine, Stanford, Calif; and VA Palo Alto Health Care System, Palo Alto, Calif.


Abstract

Background Family members of patients with established long-QT syndrome (LQTS) often lack definitive clinical findings, yet may have inherited an LQTS mutation and be at risk of sudden death. Genetic testing can identify mutations in 75% of patients with LQTS, but genetic testing of family members remains controversial. Methods and Results We used a Markov model to assess the cost-effectiveness of 3 strategies for treating an asymptomatic 10-year-old, first-degree relative of a patient with clinically evident LQTS. In the genetic testing strategy, relatives undergo genetic testing only for the mutation identified in the index patient, and relatives who test positive for the mutation are treated with β-blockers. This strategy was compared with (1) empirical treatment of relatives with β-blockers and (2) watchful waiting, with treatment only after development of symptoms. The genetic testing strategy resulted in better survival and quality-adjusted life years at higher cost, with a cost-effectiveness ratio of $67 400 per quality-adjusted life year gained compared with watchful waiting. The cost-effectiveness of the genetic testing strategy improved to less than $50 000 per quality-adjusted life year gained when applied selectively either to (1) relatives with higher clinical suspicion of LQTS (pretest probability 65% to 81%), or to (2) families with a higher than average risk of sudden death, or to (3) larger families (2 or more first-degree relatives tested). Conclusions Genetic testing of young first-degree relatives of patients with definite LQTS is moderately expensive, but can reach acceptable thresholds of cost-effectiveness when applied to selected patients.

PMID: 21139095 [PubMed - as supplied by publisher]
Cost-Effectiveness of Genetic Testing in Family Me... [Circ Cardiovasc Qual Outcomes. 2010] - PubMed result

No hay comentarios: